N-苄氧羰基-N'-叔丁氧羰基-D-2,4-二氨基丁酸 | 214852-60-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: N-苄氧羰基-N'-叔丁氧羰基-D-2,4-二氨基丁酸
• 英文名称: 2-benzyloxycarbonylamino-4-tert-butoxycarbonylamino-butyric acid
• 英文别名: (R)-2-(((Benzyloxy)carbonyl)amino)-4-((tert-butoxycarbonyl)amino)butanoic acid；(2R)-4-[(2-methylpropan-2-yl)oxycarbonylamino]-2-(phenylmethoxycarbonylamino)butanoic acid
• CAS: 214852-60-5
• 化学式: C₁₇H₂₄N₂O₆
• 分子量: 352.387
• InChiKey: ONDKXCQPYFHZPA-CYBMUJFWSA-N

物化性质

• 密度：
  1.213

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  25
• 可旋转键数：
  10
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.47
• 拓扑面积：
  114
• 氢给体数：
  3
• 氢受体数：
  6

安全信息

• 危险性防范说明：
  P261,P280,P301+P312,P302+P352,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335

反应信息

• 作为反应物：
  描述：

  N-苄氧羰基-N'-叔丁氧羰基-D-2,4-二氨基丁酸 在 palladium on activated charcoal N-甲基吗啉 、 盐酸 、 lithium hydroxide 、 氢气 、 1-羟基苯并三唑 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 、 N,N-二异丙基乙胺 作用下， 以 甲醇 、 乙醇 、 N,N-二甲基甲酰胺 、 乙腈 为溶剂， 生成 ((R)-4-tert-Butoxycarbonylamino-2-phenylmethanesulfonylamino-butyrylamino)-acetic acid
  参考文献：
  名称：

  Exploratory solid-phase synthesis of factor Xa inhibitors: Discovery and application of P3-heterocyclic amides as novel types of non-basic arginine surrogates

  摘要：

  A series of novel FXa inhibitors 2a-m and 3a-f was discovered that feature heterocyclic carboxamides tethered to a d-diaminobutyric acid sidechain. These neutral amide derivatives serve as novel P-3 d-arginine mimics. Pyrazine carboxamide scaffolds afforded the most potent FXa inhibitors (e.g., 2b IC50 = 4.6 nM). The synthesis and biological activity of two focused libraries are reported. (C) 1999 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(99)00628-9
• 作为产物：
  描述：

  二碳酸二叔丁酯 、 Cbz-D-2,4-二氨基丁酸 在 potassium carbonate 作用下， 以 1,4-二氧六环 为溶剂， 以100%的产率得到N-苄氧羰基-N'-叔丁氧羰基-D-2,4-二氨基丁酸
  参考文献：
  名称：

  Exploratory solid-phase synthesis of factor Xa inhibitors: Discovery and application of P3-heterocyclic amides as novel types of non-basic arginine surrogates

  摘要：

  A series of novel FXa inhibitors 2a-m and 3a-f was discovered that feature heterocyclic carboxamides tethered to a d-diaminobutyric acid sidechain. These neutral amide derivatives serve as novel P-3 d-arginine mimics. Pyrazine carboxamide scaffolds afforded the most potent FXa inhibitors (e.g., 2b IC50 = 4.6 nM). The synthesis and biological activity of two focused libraries are reported. (C) 1999 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(99)00628-9

文献信息

• Pyrimidinone compounds
  申请人：Lin Chu-Chung

  公开号：US20060036093A1

  公开（公告）日：2006-02-16

  This invention relates to treating inflammatory and immune diseases with certain pyrimidinone compounds that bind to CXCR3 receptors. The pyrimidinone compounds are covered by the formula (I) shown below. Each variable is defined in the specification.

  这项发明涉及使用与CXCR3受体结合的某些嘧啶酮化合物治疗炎症和免疫性疾病。这些嘧啶酮化合物由下面所示的公式（I）覆盖。每个变量在说明书中有定义。
• Acyclic 1,3-Diamine And Uses Therefor
  申请人：Casillas N. Linda

  公开号：US20070259965A1

  公开（公告）日：2007-11-08

  This invention relates to novel compounds useful in the treatment of diseases associated with TRPV4 channel receptor. More specifically, this invention relates to certain substituted amino-azepines, according to Formula I or pharmaceutically acceptable salts, hydrates, or solvates thereof, wherein: R 1 is aryl optionally substituted with CN, NO 2 , halogen or H; R 2 is H, C 1 -C 6 alkyl, C 3 -C 7 cycloalkyl, or C 3 -C 7 heterocycloalkyl; R 3 is H, OH, O—C 1 -C 6 alkyl, SH, S—C 1 -C 6 alkyl, or F; R 4 is H, C 1 -C 6 alkyl R 5 is iso-butyl, cyclohexylmethyl, or cyclopentylmethyl; and R 6 is aryl, heteroaryl.

  本发明涉及一种新型化合物，可用于治疗与TRPV4通道受体相关的疾病。更具体地说，本发明涉及按照公式I或其药学上可接受的盐、水合物或溶剂化物所替代的氨基-氮杂环化合物，其中：R1是芳基，可选用CN、NO2、卤素或H进行取代；R2是H、C1-C6烷基、C3-C7环烷基或C3-C7杂环烷基；R3是H、OH、O-C1-C6烷基、SH、S-C1-C6烷基或F；R4是H或C1-C6烷基；R5是异丁基、环己基甲基或环戊基甲基；R6是芳基或杂芳基。
• ANTIMICROBIAL POLYMYXINS FOR TREATMENT OF BACTERIAL INFECTIONS
  申请人：MICURX PHARMACEUTICALS, INC.

  公开号：US20160185823A1

  公开（公告）日：2016-06-30

  The present invention provides antimicrobial polymyxin compounds of the following formula I: or pharmaceutically acceptable salts, hydrates, or solvates thereof that are antibacterial agents, pharmaceutical compositions containing them, methods for their use, and methods for preparing these compounds.

  本发明提供以下式I的抗微生物多粘菌素化合物或其药学上可接受的盐、水合物或溶剂化物，它们是抗菌剂，包含它们的制药组合物，使用它们的方法以及制备这些化合物的方法。
• Brtnik,F.; Zaoral,M., Collection of Czechoslovak Chemical Communications, 1976, vol. 41, p. 2969 - 2977
  作者：Brtnik,F.、Zaoral,M.

  DOI：——

  日期：——
• US9771394B2
  申请人：——

  公开号：US9771394B2

  公开（公告）日：2017-09-26